Virginia Retirement System’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Virginia Retirement System’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$266K	Buy	+24,200	New	+$215K	﹤0.01%	892

Other funds holding SCLN

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Virginia Retirement System's SCLN Position: Q1 2016 in Review

Virginia Retirement System opened a new position in Sciclone Pharmaceuticals Inc (SCLN) in Q1 2016: 24,200 shares worth $266K. The stake represents ﹤0.01% of the portfolio and ranks #892 among its holdings.

142 funds tracked by Wall St. Rank hold SCLN as of Q1 2016.

Virginia Retirement System held 24,200 shares of Sciclone Pharmaceuticals Inc worth $266K as of Q1 2016.
Sciclone Pharmaceuticals Inc was a new Virginia Retirement System position in Q1 2016.
Sciclone Pharmaceuticals Inc made up ﹤0.01% of Virginia Retirement System's portfolio in Q1 2016, its #892 holding.
142 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q1 2016.

Based on Virginia Retirement System's 13F filing for Q1 2016, filed 29 Apr 2016.